Skip to main content

Table 3 Time-of-addition experiment of FR3T3

From: An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs

No

Sample

Entry inhibition (%)

Post-entry inhibition (%)

Entry and post-entry inhibition (%)

1

FR3T3 (10 μg/mL)

33.86 ± 2.19

64.04 ± 3.06

83.07 ± 4.00

2

FR3T3 (20 μg/mL)

61.68 ± 0.10

83.86 ± 2.58

93.44 ± 5.29

  1. The experiment was performed in triplicate